News
German biotech BioNTech (Nasdaq: BNTX) saw its shares dip 3.4% to $101.44 today, after it reported financial results for the ...
US subsidiary and Iceland-based Alvotech (Nasdaq: ALVO) today announced that the US Food and Drug Administration (FDA) has ...
T-cell immunotherapies (TCI) are redefining cancer care, with chimeric antigen receptor T-cell (CAR-T) therapies witnessing ...
Sweden’s Mendus (STO: IMMU), a clinical-stage drug developer, has announced the appointment of Dr Tariq Mughal as chief ...
The introduction of outpatient flat-rate payments approved today by the Swiss Federal Council poses significant risks for ...
In the USA, the Trump administration is urging congressional Republicans to include a “most favored nation” (MFN) policy in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results